Company Filing History:
1 out of 1,586 
1 out of 3,539 
Years Active: 2024
Title: Angela Hirbe: Innovator in Cancer Detection
Introduction
Angela Hirbe is a prominent inventor based in St. Louis, MO (US). She has made significant contributions to the field of cancer detection, particularly for patients with neurofibromatosis type 1. Her innovative work focuses on developing methods that allow for early and sensitive detection of cancer in these patients.
Latest Patents
Angela Hirbe holds a patent for a liquid biopsy technique designed to detect cancer early and sensitively in patients with neurofibromatosis type 1. This groundbreaking method provides a new avenue for monitoring and diagnosing cancer in a vulnerable patient population.
Career Highlights
Throughout her career, Angela has worked with esteemed institutions such as Washington University and the National Institutes of Health. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to significant advancements in medical research.
Collaborations
Angela has collaborated with notable colleagues, including Aadel Chaudhuri and Paul Jones. These partnerships have further enhanced her research and innovation in cancer detection.
Conclusion
Angela Hirbe's work in developing a liquid biopsy for cancer detection represents a significant advancement in medical technology. Her contributions are vital for improving the lives of patients with neurofibromatosis type 1.